Home/Filings/4/0001209191-21-026233
4//SEC Filing

Ashburn Theodore 4

Accession 0001209191-21-026233

CIK 0001671818other

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 4:30 PM ET

Size

11.1 KB

Accession

0001209191-21-026233

Insider Transaction Report

Form 4
Period: 2020-12-31
Ashburn Theodore
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2020-12-31$1.81/sh+1,900$3,43918,446 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-04-074,699336,546 total
    Exercise: $5.32Exp: 2029-09-16Common Stock (4,699 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-12-311,900331,975 total
    Exercise: $1.81Exp: 2028-11-13Common Stock (1,900 underlying)
  • Exercise/Conversion

    Common Stock

    2021-04-07$5.32/sh+4,699$24,99923,145 total
Footnotes (2)
  • [F1]Twenty-five percent (25%) of the shares subject to the option vested on July 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F2]Twenty-five percent (25%) of the shares subject to the option vested on September 17, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Oncorus, Inc.

CIK 0001671818

Entity typeother

Related Parties

1
  • filerCIK 0001627978

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:30 PM ET
Size
11.1 KB